InflaRx N.V.IFRXEarnings & Financial Report
Nasdaq · Health Care · Pharmaceutical Preparations
InflaRx N.V. is a clinical-stage biopharmaceutical company specializing in the development of novel anti-inflammatory therapies targeting the complement C5a pathway. Its pipeline addresses unmet medical needs for severe inflammatory diseases including autoimmune and rare inflammatory disorders, serving global patient populations.
Top Holders
| Holder | % Owned | Shares | Change | As of |
|---|---|---|---|---|
| NOS. of Above Persons | 3.20% | 1.9M | ▼ -7.10pp | 2024-02-14 |